Taro Pharmaceutical Industries Ltd (TARO) Actualités

Taro to Release First Quarter Results on July 26, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the first quarter ended June...

Krensavage Asset Management Opposes Sun's Lowball Bid for Taro

Krensavage Asset Management Opposes Sun's Lowball Bid for Taro PR Newswire NEW YORK, July 19, 2023 NEW YORK, July 19, 2023 /PRNewswire/ -- As the...

Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2023...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

        UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549    ...

Amended Statement of Beneficial Ownership (sc 13d/a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D/A (Amendment...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

        UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

        UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Taro Provides Results for Year Ended March 31, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year...

Taro to Release Full Year Results on May 23, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K REPORT OF FOREIGN PRIVATE...

Taro Provides Results for December 31, 2022

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine...

Taro to Release Third Quarter Results on January 24, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended...